19:34 , May 17, 2018 |  BC Innovations  |  Finance

Europe’s piece of the pie

With China’s rising infrastructure for life science innovation and the unabated growth of U.S. science, Europe has two cards to play that can help it compete globally: expertise in key core technologies and its centralized...
22:58 , Oct 6, 2017 |  BioCentury  |  Emerging Company Profile

Metabolic contrarian

Antag Therapeutics ApS is going against the grain, blocking rather than boosting the effects of glucose-dependent insulinotropic polypeptide to treat obesity and diabetes. While several other companies are developing agonists to enhance the peptide’s glucose-regulating...
18:35 , Jul 6, 2017 |  BC Week In Review  |  Financial News

Novo Seeds invests €2.7M in Antag

On June 28, metabolic start-up Antag Therapeutics ApS (Copenhagen, Denmark) said it received a €2.7 million ($3 million) investment from Novo Seeds, the early stage investment arm of Novo Holdings A/S (Hellerup, Denmark). Antag is...
20:42 , Jun 28, 2017 |  BC Extra  |  Financial News

Novo Seeds invests €2.7M in Antag

Metabolic start-up Antag Therapeutics ApS (Copenhagen, Denmark) said it has received a €2.7 million ($3 million) investment from Novo Seeds, the early stage investment arm of Novo Holdings A/S (Hellerup, Denmark). Antag is developing peptide...